415 related articles for article (PubMed ID: 28587875)
1. The effectiveness of the anti-CD11d treatment is reduced in rat models of spinal cord injury that produce significant levels of intraspinal hemorrhage.
Geremia NM; Hryciw T; Bao F; Streijger F; Okon E; Lee JHT; Weaver LC; Dekaban GA; Kwon BK; Brown A
Exp Neurol; 2017 Sep; 295():125-134. PubMed ID: 28587875
[TBL] [Abstract][Full Text] [Related]
2. Early anti-inflammatory treatment reduces lipid peroxidation and protein nitration after spinal cord injury in rats.
Bao F; Chen Y; Dekaban GA; Weaver LC
J Neurochem; 2004 Mar; 88(6):1335-44. PubMed ID: 15009633
[TBL] [Abstract][Full Text] [Related]
3. Anti-CD11d antibody treatment reduces free radical formation and cell death in the injured spinal cord of rats.
Bao F; Dekaban GA; Weaver LC
J Neurochem; 2005 Sep; 94(5):1361-73. PubMed ID: 15992367
[TBL] [Abstract][Full Text] [Related]
4. Methylprednisolone causes minimal improvement after spinal cord injury in rats, contrasting with benefits of an anti-integrin treatment.
Weaver LC; Gris D; Saville LR; Oatway MA; Chen Y; Marsh DR; Hamilton EF; Dekaban GA
J Neurotrauma; 2005 Dec; 22(12):1375-87. PubMed ID: 16379576
[TBL] [Abstract][Full Text] [Related]
5. CD11d integrin blockade reduces the systemic inflammatory response syndrome after spinal cord injury.
Bao F; Brown A; Dekaban GA; Omana V; Weaver LC
Exp Neurol; 2011 Oct; 231(2):272-83. PubMed ID: 21784069
[TBL] [Abstract][Full Text] [Related]
6. Anti-CD11d monoclonal antibody treatment for rat spinal cord compression injury.
Hurtado A; Marcillo A; Frydel B; Bunge MB; Bramlett HM; Dietrich WD
Exp Neurol; 2012 Feb; 233(2):606-11. PubMed ID: 21145887
[TBL] [Abstract][Full Text] [Related]
7. CD11d Antibody Treatment Improves Recovery in Spinal Cord-Injured Mice.
Geremia NM; Bao F; Rosenzweig TE; Hryciw T; Weaver L; Dekaban GA; Brown A
J Neurotrauma; 2012 Feb; 29(3):539-50. PubMed ID: 22044160
[TBL] [Abstract][Full Text] [Related]
8. An anti-CD11d integrin antibody reduces cyclooxygenase-2 expression and protein and DNA oxidation after spinal cord injury in rats.
Bao F; Chen Y; Dekaban GA; Weaver LC
J Neurochem; 2004 Sep; 90(5):1194-204. PubMed ID: 15312174
[TBL] [Abstract][Full Text] [Related]
9. Transient blockade of the CD11d/CD18 integrin reduces secondary damage after spinal cord injury, improving sensory, autonomic, and motor function.
Gris D; Marsh DR; Oatway MA; Chen Y; Hamilton EF; Dekaban GA; Weaver LC
J Neurosci; 2004 Apr; 24(16):4043-51. PubMed ID: 15102919
[TBL] [Abstract][Full Text] [Related]
10. Timing and duration of anti-alpha4beta1 integrin treatment after spinal cord injury: effect on therapeutic efficacy.
Fleming JC; Bao F; Chen Y; Hamilton EF; Gonzalez-Lara LE; Foster PJ; Weaver LC
J Neurosurg Spine; 2009 Nov; 11(5):575-87. PubMed ID: 19929361
[TBL] [Abstract][Full Text] [Related]
11. A therapeutic time window for anti-CD 11d monoclonal antibody treatment yielding reduced secondary tissue damage and enhanced behavioral recovery following severe spinal cord injury.
Ditor DS; Bao F; Chen Y; Dekaban GA; Weaver LC
J Neurosurg Spine; 2006 Oct; 5(4):343-52. PubMed ID: 17048772
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling in anti-CD11d mAb-treated spinal cord-injured rats.
Gris P; Tighe A; Thawer S; Hemphill A; Oatway M; Weaver L; Dekaban GA; Brown A
J Neuroimmunol; 2009 Apr; 209(1-2):104-13. PubMed ID: 19250688
[TBL] [Abstract][Full Text] [Related]
13. Anti-CD11d integrin antibody treatment restores normal serotonergic projections to the dorsal, intermediate, and ventral horns of the injured spinal cord.
Oatway MA; Chen Y; Bruce JC; Dekaban GA; Weaver LC
J Neurosci; 2005 Jan; 25(3):637-47. PubMed ID: 15659600
[TBL] [Abstract][Full Text] [Related]
14. Comparison of effects of methylprednisolone and anti-CD11d antibody treatments on autonomic dysreflexia after spinal cord injury.
Gris D; Marsh DR; Dekaban GA; Weaver LC
Exp Neurol; 2005 Aug; 194(2):541-9. PubMed ID: 15890340
[TBL] [Abstract][Full Text] [Related]
15. A monoclonal antibody to CD11d reduces the inflammatory infiltrate into the injured spinal cord: a potential neuroprotective treatment.
Saville LR; Pospisil CH; Mawhinney LA; Bao F; Simedrea FC; Peters AA; O'Connell PJ; Weaver LC; Dekaban GA
J Neuroimmunol; 2004 Nov; 156(1-2):42-57. PubMed ID: 15465595
[TBL] [Abstract][Full Text] [Related]
16. Transient blockage of the CD11d/CD18 integrin reduces contusion volume and macrophage infiltration after traumatic brain injury in rats.
Utagawa A; Bramlett HM; Daniels L; Lotocki G; Dekaban GA; Weaver LC; Dietrich WD
Brain Res; 2008 May; 1207():155-63. PubMed ID: 18374312
[TBL] [Abstract][Full Text] [Related]
17. A CD11d monoclonal antibody treatment reduces tissue injury and improves neurological outcome after fluid percussion brain injury in rats.
Bao F; Shultz SR; Hepburn JD; Omana V; Weaver LC; Cain DP; Brown A
J Neurotrauma; 2012 Sep; 29(14):2375-92. PubMed ID: 22676851
[TBL] [Abstract][Full Text] [Related]
18. Alpha4beta1 integrin blockade after spinal cord injury decreases damage and improves neurological function.
Fleming JC; Bao F; Chen Y; Hamilton EF; Relton JK; Weaver LC
Exp Neurol; 2008 Dec; 214(2):147-59. PubMed ID: 19038604
[TBL] [Abstract][Full Text] [Related]
19. The immunomodulator decoy receptor 3 improves locomotor functional recovery after spinal cord injury.
Chiu CW; Huang WH; Lin SJ; Tsai MJ; Ma H; Hsieh SL; Cheng H
J Neuroinflammation; 2016 Jun; 13(1):154. PubMed ID: 27316538
[TBL] [Abstract][Full Text] [Related]
20. C-C motif chemokine ligand 20 regulates neuroinflammation following spinal cord injury via Th17 cell recruitment.
Hu J; Yang Z; Li X; Lu H
J Neuroinflammation; 2016 Jun; 13(1):162. PubMed ID: 27334337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
